CD8A and neoplasm: More importantly, we demonstrated that IL-2 linked to NKG2D-Fc led to significant proliferation of the tumor-specific CD8+ T-cell at the tumor loci and resulted in potent therapeutic anti-tumor effects in TC-1 tumor-bearing mice that received the therapeutic HPV16/E7 DNA vaccine.